Integron occurrence is linked to reduced biocide susceptibility in multidrug resistant Pseudomonas aeruginosa

References

• de Bentzmann S, Plésiat P. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol. 2011;13:1655–1665.10.1111/j.1462-2920.2011.02469.x
   PubMedGoogle Scholar
• Morita Y, Tomida J, Kawamura Y. Responses of Pseudomonas aeruginosa to antimicrobials. Front Microbiol. 2014;4. Article 422. doi: 10.3389/fmicb.2013.00422
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Exp Rev Pharmacoecon Outcomes Res. 2010;10(4):441–451.10.1586/erp.10.49
   PubMed Web of Science ®Google Scholar
• Ogbulie JN, Adieze IE, Nwankwo NC. Susceptibility pattern of some clinical bacterial isolates to selected antibiotics and disinfectants. Polish J Microbiol. 2008;57:199–204.
   PubMed Web of Science ®Google Scholar
• Loveday HP, Wilson JA, Kerr K, et al. Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review. J Hosp Infect. 2014;86:7–15.10.1016/j.jhin.2013.09.010
   PubMed Web of Science ®Google Scholar
• Ndip RN, Dilonga HM, Ndip LM, et al. Pseudomonas aeruginosa isolates recovered from clinical and environmental samples in Buea, Cameroon: current status on biotyping and antibiogram. Trop Med Int Health. 2005;10:74–81.10.1111/tmi.2005.10.issue-1
   PubMed Web of Science ®Google Scholar
• Russell AD, Hammond SA, Morgan JR. Bacterial resistance to antiseptics and disinfectants. J Hosp Infect. 1986;7:213–225.10.1016/0195-6701(86)90071-X
   PubMed Web of Science ®Google Scholar
• Pal C, Bengtsson-Palme J, Kristiansson E, et al. Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential. BMC Genomics. 2015;16 (1):964. doi: 10.1186/s12864-015-2153-5.
   PubMed Web of Science ®Google Scholar
• Mazel D. Integrons: agents of bacterial evolution. Nat Rev. 2006;4:608–620.
   Google Scholar
• Carattoli A. Importance of integrons in the diffusion of resistance. Vet Res. 2001;32:243–259.10.1051/vetres:2001122
   PubMed Web of Science ®Google Scholar
• Boucher Y, Labbate M, Koenig JE, et al. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends Microbial. 2007;15:301–309.10.1016/j.tim.2007.05.004
   PubMed Web of Science ®Google Scholar
• Malek MM, Amer FA, Allam AA, et al. Occurrence of classes I and II integrons in Enterobacteriaceae collected from Zagazig University Hospitals, Egypt. Front Microbiol. 2015;6. Article 601. doi: 10.3389/fmicb.2015.00601.
   PubMed Web of Science ®Google Scholar
• Kazama H, Hamashima H, Sasatsus M, et al. Distribution of antiseptic resistance genes qacE and qacE∆1 in Gram-negative bacteria. FEMS Microbiol Lett. 1998;165:295–299.
   PubMed Web of Science ®Google Scholar
• Laraki N, Galleni M, Thamm I, et al. Structure of In31, a blaIMP containing Pseudomonas aeruginosa integrin phyletically related to IN5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother. 1999;43:890–901.
   PubMed Web of Science ®Google Scholar
• Canal N, Meneghetti KL, de Almeida CP, et al. Characterization of the variable region in the class 1 integron of antimicrobial-resistant Escherichia coli isolated from surface water. Braz J Microbiol. 2016;47(2):337–344.10.1016/j.bjm.2016.01.015
   PubMed Web of Science ®Google Scholar
• Public Health England (PHE). UK standards for microbiology investigations: identification of pseudomonas species and other non-glucose fermenters. 2015; SMI ID 17 Available from: https://www.gov.uk/government/publications/smi-id-17-identification-of-glucose-non-fermenting-gram-negative-rods
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Twenty-fourth informational supplement. Approved standards. 2014; Document M100-S24. Available from: http://clsi.org/m100/
   Google Scholar
• Kawamura-Sato K, Wachino J-I, Kondo T, et al. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species. J Antimicrob Chemother. 2010;65:1975–1983.10.1093/jac/dkq227
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia (USP). USP 30-NF 25. 2007. Available from: http://www.usp.org/usp-nf
   Google Scholar
• White PA, Melver CJ, Deng YM, et al. Characterization of two new gene cassettes, aadA5 and dfrA17. FEMS Microbiol Lett. 2000;45:2658–2661.
   Google Scholar
• Ploy MC, Denis F, Courvalin P, et al. Molecular characterization of integrons in Acinetobacter baumanii: description of a hybrid class 2 integron. Antimicrob Agents Chemother. 2002;44:2684–2688.
   Web of Science ®Google Scholar
• Sacha P, Jaworowska J, Ojadana P, et al. Occurrence of the aacA4 gene among multidrug resistant strains of Pseudomonas aeruginosa isolated from bronchial secretions obtained from the intensive therapy unit at university hospital in Bialystok, Poland. Folia Histochem Cytobiol. 2012;50(2):322–324.10.5603/FHC.2012.0043
   PubMed Web of Science ®Google Scholar
• Mahmoud AB, Zahran WH, Hindawi GR, et al. Prevalence of multidrug-resistant Pseudomonas aeruginosa in patients with nosocomial infections at a university hospital in Egypt, with special reference to typing methods. J Virol Microbiol. 2013. Article ID 290047, 13 pages. doi: 10.5171/2013.290047
   Google Scholar
• Hassuna NA, Mohamed AHI, Abo-Eleuoon SM, et al. High prevalence of multidrug resistant Pseudomonas aeruginosa recovered from infected burn wounds in children. ACMicrob. 2015;6(4):1–7.
   Google Scholar
• Chander A, Raza M. Antimicrobial susceptibility patterns of Pseudomonas aeruginosa clinical isolates at a tertiary care hospital in Kathmandu, Nepal. Asian J Pharm Clin Res. 2013;6(3):235–238.
   Google Scholar
• Pathmanathan SG, Samat NA, Mohamed R. Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian hospital. Malays J Med Sci. 2009;16(2):27–32.
   PubMedGoogle Scholar
• Zafer MM, Al-Agamy MH, El-Mahallawy HA, et al. Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients. Biomed Res Int. 2014; 8 pages. doi: 10.1155/2014/101635. Article ID101635.
   Web of Science ®Google Scholar
• Afifi MM, Suelam II, Soliman MT, et al. Prevalence and antimicrobial susceptibility pattern of pseudomonas aeruginosa isolated from environmental and clinical samples in upper Egypt. Int J Biol Chem. 2013;7(2):47–57.10.3923/ijbc.2013.47.57
   Google Scholar
• Fatima A, Naqvi S, Khaliq S, et al. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa isolated from patients of lower respiratory tract infections. SpringerPlus. 2012;1:70. doi: 10.1186/2193-1801-1-70.
   PubMed Web of Science ®Google Scholar
• Bouza E, Garcia-Gorrote F, Cercenado E, et al. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa study group. Antimicrob Agents Chemother. 1999;43(4):981–982.
   PubMed Web of Science ®Google Scholar
• Miliani K, L’Hériteau F, Lacavé L, et al. Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France. J Hosp Infect. 2011;77(4):343–347.10.1016/j.jhin.2010.11.024
   PubMed Web of Science ®Google Scholar
• Lambert RJW, Joynson JA, Forbes B. The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides. J Appl Microbiol. 2001;91:972–984.10.1046/j.1365-2672.2001.01460.x
   PubMed Web of Science ®Google Scholar
• Stickler DJ, Thomas B, Chawla JC. Antiseptic and antibiotic resistance in gram-negative bacteria causing urinary tract infection in spinal cord injured patients. Paraplegia. 1980;19(1):50–58.
   Google Scholar
• Knapp L, Amézquita A, McClure P, et al. Development of a protocol for predicting bacterial resistance to microbicides. Appl Environ Microbiol. 2015;81(8):2652–2659.10.1128/AEM.03843-14
   PubMed Web of Science ®Google Scholar
• Russell AD. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol. 2002;92(s1):121S–135S.10.1046/j.1365-2672.92.5s1.12.x
   Google Scholar
• Odumosu BT, Adeniyi BA, Chandra R. Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria. J Annals Clin Microbiol Antimicrob. 2013;10:12–29.
   Google Scholar
• Xu Z, Li L, Shirtliff M, et al. Occurrence and characteristics of class 1 and 2 integrons in pseudomonas aeruginosa isolates from patients in southern China. J Clin Microbiol. 2009;47:230–234.10.1128/JCM.02027-08
   PubMed Web of Science ®Google Scholar
• Nikokar I, Tishayar A, Flakiyan Z, et al. Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran. Iran J Microbiol. 2013;5(1):36–41.
   PubMedGoogle Scholar
• Ruiz-Martínez L, López-Jiménez L, Fusté E, et al. Class 1 integrons in environmental and clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents. 2011;38:398–402.10.1016/j.ijantimicag.2011.06.016
   PubMed Web of Science ®Google Scholar
• Mahzounieh M, Khoshnood S, Ebrahimi A, et al. Detection of antiseptic-resistance genes in Pseudomonas and Acinetobacter spp. isolated from burn patients. Jundishapur J Nat Pharm Prod. 2014;9(2):e15402.
   PubMedGoogle Scholar